AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report)’s share price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2.26 and traded as high as $2.46. AIkido Pharma shares last traded at $2.32, with a volume of 7,027 shares changing hands.
AIkido Pharma Stock Performance
The business’s 50 day simple moving average is $2.41 and its 200-day simple moving average is $2.26. The stock has a market capitalization of $12.71 million, a price-to-earnings ratio of -0.60 and a beta of 0.93.
About AIkido Pharma
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Featured Stories
- Five stocks we like better than AIkido Pharma
- Conference Calls and Individual Investors
- AMD is Down 35%. Now is the Time to Buy the Dip
- Technology Stocks Explained: Here’s What to Know About Tech
- Amazon Stands Tall: New Highs Are in Sight
- What Investors Need to Know About Upcoming IPOs
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
